Skip to main content
ConductScienceScienceDex

Andreeff, Michael

From the FY2023 NIH awards this investigator leads as contact PI. The department is the award's.

FY2023 NIH rank #20,447
Unclaimed recordClaim profile
  • R01 Holder

Researcher identity and coverage

Current affiliation
Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
NIH RePORTER identity
Profile ID unavailableSearch this ID in NIH RePORTER
ORCID iD
No ORCID iD on recordA researcher can add one by claiming this profile.
ScienceDex PI coverage
FY2008 through FY2023Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.

FY2023 award categories

  • Internal Medicine

NIH Funding · FY2023

Linked Award Amount
$596.3K
Full award amounts, FY2023
Award Records
2
Records listing this PI
Award-Linked Rank
#20,447
By linked amount among FY2023 PIs
Earliest Year Loaded
2008
ScienceDex PI coverage

One scientist record

NIH portfolios and SHARE

This is the common ScienceDex page for Andreeff, Michael. NIH portfolio memberships are contextual views of this scientist, while SHARE Score, S-Index, and S-Impact describe the researcher's global sharing track record.

Review metric definitions

FY2024 NIH portfolio memberships

No institute-level portfolio release is available for this scientist and fiscal year yet. Existing award history remains unchanged above.

Researcher-associated datasets

These datasets are linked to this researcher's ShareScore identity. This does not by itself prove that an NIH portfolio funded each dataset.

No compatible author-to-dataset release is published. Dataset records are unavailable, not zero.

Award-linked funding history

Linked NIH award amounts and rank by fiscal year.

FY2023 award records by amount

NIH award records listing Andreeff, Michael as a PI. Multi-PI records show the full award amount for context.

  • 5R01FD006118-03R01Contact PI
    Ph1/2 Study of the Imipridone ONC201 for Treatment of AML IND125,203 (12/23/2014)
    UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
    $373.7K
    award amount
  • 5R21CA267401-02R21Contact PI
    Therapeutic targeting of p53 reactivation-induced OXPHOS dependency and stress responses to overcome resistance to venetoclax/HMA in AML
    UT MD Anderson Cancer Center · Internal Medicine (NIH department code)
    $222.7K
    award amount

Award organization

Organizations that administered FY2023 awards listing Andreeff, Michael as a PI.

FY2023 award administered by UT MD Anderson Cancer Center (TX).

Coverage and award-record milestones

Computed from the fiscal years currently available in ScienceDex.

  1. 2008
    First NIH Award
    UT MD Anderson Cancer Center
  2. 2008
    $500K Cumulative Funding
  3. 2008
    $1M Cumulative Funding
  4. 2008
    $2M Cumulative Funding
  5. 2008
    Entered Top 50% Nationally
    Ranked #1850
  6. 2008
    Entered Top 25% Nationally
    Ranked #1850
  7. 2008
    Entered Top 10% Nationally
    Ranked #1850
  8. 2009
    $5M Cumulative Funding
  9. 2010
    R01 Grant Holder
  10. 2011
    $10M Cumulative Funding

Explore further

Find collaborators for Andreeff, Michael

Search NIH-funded principal investigators by topic, department, or activity.

Open Find Collaborators →

Benchmark grant budgets

Compare median NIH grant budgets across departments, mechanisms, and years.

Open Grant Budget Benchmark →